vs
Side-by-side financial comparison of GLOBAL INDUSTRIAL Co (GIC) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
GLOBAL INDUSTRIAL Co is the larger business by last-quarter revenue ($345.6M vs $207.8M, roughly 1.7× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 4.2%, a 53.2% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $19.2M).
Global Industrial Company is a Port Washington, New York–based company providing industrial and MRO products through a system of branded e-Commerce websites and relationship marketers in North America. The primary brand is Global Industrial.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
GIC vs IDYA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $345.6M | $207.8M |
| Net Profit | $14.6M | $119.2M |
| Gross Margin | 34.5% | — |
| Operating Margin | 5.7% | 52.2% |
| Net Margin | 4.2% | 57.4% |
| Revenue YoY | 14.3% | — |
| Net Profit YoY | 36.4% | 330.1% |
| EPS (diluted) | $0.37 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $345.6M | — | ||
| Q3 25 | $353.6M | $207.8M | ||
| Q2 25 | $358.9M | — | ||
| Q1 25 | $321.0M | — | ||
| Q4 24 | $302.3M | — | ||
| Q3 24 | $342.4M | $0 | ||
| Q2 24 | $347.8M | $0 | ||
| Q1 24 | $323.4M | $0 |
| Q4 25 | $14.6M | — | ||
| Q3 25 | $18.8M | $119.2M | ||
| Q2 25 | $25.1M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $10.7M | — | ||
| Q3 24 | $16.8M | $-51.8M | ||
| Q2 24 | $20.3M | $-52.8M | ||
| Q1 24 | $13.2M | $-39.6M |
| Q4 25 | 34.5% | — | ||
| Q3 25 | 35.6% | — | ||
| Q2 25 | 37.1% | — | ||
| Q1 25 | 34.9% | — | ||
| Q4 24 | 33.8% | — | ||
| Q3 24 | 34.0% | — | ||
| Q2 24 | 35.2% | — | ||
| Q1 24 | 34.3% | — |
| Q4 25 | 5.7% | — | ||
| Q3 25 | 7.4% | 52.2% | ||
| Q2 25 | 9.3% | — | ||
| Q1 25 | 5.7% | — | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | 6.5% | — | ||
| Q2 24 | 7.6% | — | ||
| Q1 24 | 5.4% | — |
| Q4 25 | 4.2% | — | ||
| Q3 25 | 5.3% | 57.4% | ||
| Q2 25 | 7.0% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 5.8% | — | ||
| Q1 24 | 4.1% | — |
| Q4 25 | $0.37 | — | ||
| Q3 25 | $0.48 | $1.33 | ||
| Q2 25 | $0.65 | — | ||
| Q1 25 | $0.35 | — | ||
| Q4 24 | $0.28 | — | ||
| Q3 24 | $0.44 | $-0.60 | ||
| Q2 24 | $0.52 | $-0.68 | ||
| Q1 24 | $0.34 | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $67.5M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $313.2M | $1.1B |
| Total Assets | $580.8M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.5M | — | ||
| Q3 25 | $67.2M | $786.9M | ||
| Q2 25 | $55.1M | — | ||
| Q1 25 | $39.0M | — | ||
| Q4 24 | $44.6M | — | ||
| Q3 24 | $38.9M | $920.0M | ||
| Q2 24 | $38.8M | $701.7M | ||
| Q1 24 | $29.9M | $698.8M |
| Q4 25 | $313.2M | — | ||
| Q3 25 | $316.0M | $1.1B | ||
| Q2 25 | $305.2M | — | ||
| Q1 25 | $287.9M | — | ||
| Q4 24 | $281.1M | — | ||
| Q3 24 | $279.2M | $1.2B | ||
| Q2 24 | $270.4M | $931.7M | ||
| Q1 24 | $260.2M | $935.3M |
| Q4 25 | $580.8M | — | ||
| Q3 25 | $602.5M | $1.2B | ||
| Q2 25 | $586.5M | — | ||
| Q1 25 | $536.7M | — | ||
| Q4 24 | $520.7M | — | ||
| Q3 24 | $531.6M | $1.2B | ||
| Q2 24 | $542.5M | $973.7M | ||
| Q1 24 | $517.4M | $961.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.0M | $142.2M |
| Free Cash FlowOCF − Capex | $19.2M | $142.2M |
| FCF MarginFCF / Revenue | 5.6% | 68.4% |
| Capex IntensityCapex / Revenue | 0.2% | 0.0% |
| Cash ConversionOCF / Net Profit | 1.37× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $74.7M | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.0M | — | ||
| Q3 25 | $22.7M | $142.2M | ||
| Q2 25 | $31.7M | — | ||
| Q1 25 | $3.4M | — | ||
| Q4 24 | $15.9M | — | ||
| Q3 24 | $9.6M | $-49.2M | ||
| Q2 24 | $18.8M | $-32.9M | ||
| Q1 24 | $6.4M | $-43.8M |
| Q4 25 | $19.2M | — | ||
| Q3 25 | $22.0M | $142.2M | ||
| Q2 25 | $30.3M | — | ||
| Q1 25 | $3.2M | — | ||
| Q4 24 | $15.2M | — | ||
| Q3 24 | $8.7M | $-49.7M | ||
| Q2 24 | $17.9M | $-33.9M | ||
| Q1 24 | $5.1M | $-45.1M |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 6.2% | 68.4% | ||
| Q2 25 | 8.4% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | 0.0% | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.4% | — |
| Q4 25 | 1.37× | — | ||
| Q3 25 | 1.21× | 1.19× | ||
| Q2 25 | 1.26× | — | ||
| Q1 25 | 0.25× | — | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | 0.57× | — | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 0.48× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
